Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cir Cir ; 81(2): 138-42, 2013.
Article in Spanish | MEDLINE | ID: mdl-23522315

ABSTRACT

INTRODUCTION: The left main coronary artery aneurysm is rare, with an incidence of 0.1%, being the atherosclerosis its main etiology. Angiography is the gold standard for diagnosis and treatment. Depending on the severity of coexisting coronary stenosis, patients with left main coronary artery aneurysms can be effectively managed either surgical or pharmacologically. CLINICAL CASE: We present a case of a 44 year-old male with a history of obesity, smoking and dyslipidemia, complaining of oppressive chest pain, dyspnea and diaphoresis. An electrocardiogram showed an ST-segment elevation on the anterior and lateral wall and positive enzymatic curve for infarction. He was initially treated with streptokinase with no reperfusion evidence after 3 hours of the onset of symptoms, so he underwent to rescue angioplasty. Angiography reported left main coronary artery aneurysm thrombosis. Afterwards, he presented cardiogenic shock and was revascularized with a coronary artery bypass graft of the mammary artery to the left anterior descending artery and the saphenous vein to the obtuse marginal, however he did not survive. Determination for 4G/5G PAI-1 polymorphism, glycoprotein IIIa PLA1/A2 gene and Glu298Asp polymorphism of the endothelial nitric oxide synthase gene was performed. CONCLUSIONS: Left main coronary artery aneurysms are rare, finding ONE in an acute myocardial infarction is a serious situation because of the challenging reperfusion techniques that are implied, such as in this case. The search for genetic factors related with hypofibrinolysis could guide stratification and therapy towards medical surgical or interventional management.


Subject(s)
Coronary Aneurysm/complications , Coronary Thrombosis/etiology , Myocardial Infarction/etiology , Adult , Alleles , Combined Modality Therapy , Dyslipidemias/complications , Fatal Outcome , Fibrinolysis/genetics , Humans , Integrin beta3/genetics , Male , Myocardial Infarction/drug therapy , Myocardial Infarction/genetics , Myocardial Infarction/surgery , Myocardial Reperfusion , Myocardial Revascularization , Nitric Oxide Synthase Type III/genetics , Obesity/complications , Plasminogen Activator Inhibitor 1/genetics , Shock, Cardiogenic/etiology , Smoking/adverse effects , Streptokinase/therapeutic use , Thrombophilia/complications , Thrombophilia/genetics
2.
Rev Med Inst Mex Seguro Soc ; 50(5): 559-63, 2012.
Article in Spanish | MEDLINE | ID: mdl-23282274

ABSTRACT

BACKGROUND: pheochromocytoma is a neuroendocrine tumor that secretes high levels of catecholamines and it is able to exert serious cardiovascular effects. The cardiac involvement is the most frequent, with reported conditions such as transient myocardial dysfunction, acute coronary syndrome and ventricular arrhythmias. CLINICAL CASE: we reported a 36 year-old woman without cardiovascular history. She presented with an adrenergic crisis after surgery leading to acute heart failure and acute myocardial infarction. The electrocardiogram showed an ST-segment elevation and positive enzymatic curve, motion alterations in echocardiography and ventriculography without coronary arteries lesions. She was screened for secondary hypertension protocol with a 24 hour urine free catecholamine sample that was clearly elevated. Abdomen computed tomography and magnetic resonance imaging showed a tumor located in the right adrenal gland and she underwent surgical resection. CONCLUSIONS: pheochromocytoma has different clinical presentations that may delay the diagnosis. Early recognition of catecholamine-induced cardiomyopathy and adequate management reduces morbidity and mortality.


Subject(s)
Adrenal Gland Neoplasms/complications , Myocardial Infarction/etiology , Pheochromocytoma/complications , Adult , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...